Worth Asset Management LLC Has $445,000 Stock Holdings in SPDR S&P Biotech ETF $XBI

Worth Asset Management LLC reduced its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 86.9% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 3,485 shares of the exchange traded fund’s stock after selling 23,187 shares during the period. Worth Asset Management LLC’s holdings in SPDR S&P Biotech ETF were worth $445,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in XBI. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the 4th quarter valued at about $27,000. Intesa Sanpaolo Wealth Management acquired a new position in SPDR S&P Biotech ETF during the 4th quarter worth approximately $30,000. SHP Wealth Management acquired a new position in SPDR S&P Biotech ETF during the 4th quarter worth approximately $31,000. Legacy Wealth Managment LLC ID bought a new position in SPDR S&P Biotech ETF in the fourth quarter worth approximately $32,000. Finally, Smartleaf Asset Management LLC bought a new position in SPDR S&P Biotech ETF in the fourth quarter worth approximately $32,000.

SPDR S&P Biotech ETF Stock Performance

Shares of SPDR S&P Biotech ETF stock opened at $145.86 on Tuesday. The stock has a market capitalization of $9.31 billion, a PE ratio of 11.47 and a beta of 0.85. SPDR S&P Biotech ETF has a 52 week low of $80.90 and a 52 week high of $146.77. The stock has a 50 day moving average price of $133.84 and a two-hundred day moving average price of $127.95.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.